Episode 429: 2023-2024 Ophthalmology Residency Match Review

Dr. Omar Shakir joins to discuss in-office vitreoretinal surgery, including a deep dive on pros/cons, effects for the healthcare system at large, and how he responds to major criticisms.Relevant Financial Disclosures: Dr. Shakir is a shareholder in iOR Partners.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Drs. Yoshi Yonekawa and Sarwar Zahid join to preview the June 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Four recently matched medical students into ophthalmology residency join to discuss their experiences in the residency match.Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Drs. Kat Talcott and Sarwar Zahid join to preview the May 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.Relevant Financial Disclosures: Dr. Zahid has equity in Eyedaptic.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Drs. Avni Finn, Basil Williams, and Yoshihiro Yonekawa join to discuss their biggest learning pearls from the 2024 Vit-Buckle Society Annual Meeting.Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Dr. Marianeli Rodriguez joins to preview the April 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech and Regeneron.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Drs. Avni Finn and Sarwar Zahid join to discuss three recent publications from major ophthalmology journals.Diabetic Retinopathy and Quality of Life (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2814583)Artificial Intelligence in Ophthalmology Review (https://www.ophthalmologyretina.org/article/S2468-6530(24)00044-7/abstract)Proliferative Sickle Cell Retinopathy Surgical Outcomes (https://www.ophthalmologyretina.org/article/S2468-6530(24)00049-6/abstract)Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Dr. Philip Rosenfeld joins to discuss the Angiogenesis 2024 meeting, with topics covered including imaging breakthroughs for age-related macular degeneration, geographic atrophy treatment benefits and risks, and the importance of molarity in assessing efficacy and safety of intravitreal agents.Relevant Financial Disclosures: Dr. Rosenfeld has consulted for Regeneron and Zeiss. Dr. Sridhar has consulted for Apellis, Genentech, Iveric, and Regeneron.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi